A survey showed that many Americans were interested in obesity treatments like Wegovy but lost interest when confronted with the price and other factors.
Tirzepatide, a drug approved for diabetes and on the fast track for approval as a weight loss therapy, works through a unique ability to activate two different mechanisms the body uses to control insulin secretion and energy balance, Duke Health researchers report.
Tirzepatide Stimulates Insulin Secretion Uniquely miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Andrew T. Hattersley, DBE, FMedSci, FRS
2021 Harold Hamm International Prize for Biomedical Research in Diabetes award winner view more
Credit: University of Exeter Medical School, U.K. OKLAHOMA CITY - Andrew T. Hattersley, DBE, FMedSci, FRS, has been named the recipient of the 2021 Harold Hamm International Prize for Biomedical Research in Diabetes. Hattersley, Professor of Molecular Medicine, University of Exeter Medical School, U.K., was nominated by Alvin Powers, M.D., Vanderbilt University; and Juleen Zierath, Ph.D., Karolinska Institute, Sweden, and University of Copenhagen, Denmark. The Hamm Prize recognizes and encourages lasting advances in the field of diabetes research. It is awarded to an individual who has either demonstrated lifelong contributions to the field or realized a singular advance, especially one that promotes curative potential. The honor includes a $250,000 award - the largest of its kind in the world - and will be award